3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Salivary Gland Neoplasms
4
Oropharyngeal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Penile Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Interventions
pembrolizumab
30
Nivolumab
10
Cyclophosphamide
9
fludarabine
7
atezolizumab
7
aldesleukin
5
Paclitaxel
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
5
Carboplatin
5
Biopsy
5
cemiplimab
4
Trastuzumab
4
Interleukin-2
4
Docetaxel
4
Cisplatin
4
spartalizumab
3
durvalumab
3
Specimen Handling
3
Polymerase Chain Reaction
3
Gene Expression Profiling
3
Fulvestrant
3
Fluorouracil
3
tisotumab vedotin
2
tislelizumab
2
palbociclib
2
fludarabine phosphate
2
entinostat
2
avelumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Vorinostat
×
Head & Neck
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled